Literature DB >> 34905071

[Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34905071     DOI： 10.1007/s00347-021-01549-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  118 in total

1.  Long-term follow-up of idiopathic central serous chorioretinopathy without laser.

Authors:  D Bujarborua
Journal:  Acta Ophthalmol Scand       Date:  2001-08

2.  Photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  M Battaglia Parodi; S Da Pozzo; G Ravalico
Journal:  Retina       Date:  2003-04       Impact factor: 4.256

3.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Elodie Bousquet; Sophie Bonnin; Sarah Mrejen; Valérie Krivosic; Ramin Tadayoni; Alain Gaudric
Journal:  Retina       Date:  2018-03       Impact factor: 4.256

4.  A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.

Authors:  So Hyun Bae; Jang Won Heo; Cinoo Kim; Tae Wan Kim; Joo Yong Lee; Su Jeong Song; Tae Kwann Park; Sang Woong Moon; Hum Chung
Journal:  Am J Ophthalmol       Date:  2011-07-13       Impact factor: 5.258

Review 5.  OCT angiography and evaluation of the choroid and choroidal vascular disorders.

Authors:  Enrico Borrelli; David Sarraf; K Bailey Freund; Srinivas R Sadda
Journal:  Prog Retin Eye Res       Date:  2018-07-27       Impact factor: 21.198

6.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

7.  Systemic Corticosteroid Use after Central Serous Chorioretinopathy Diagnosis.

Authors:  Amee D Azad; Maggie Zhou; Armin R Afshar; Sophie J Bakri; Suzann Pershing
Journal:  Ophthalmology       Date:  2020-06-30       Impact factor: 12.079

8.  Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy.

Authors:  A Ayata; S Tatlipinar; T Kar; M Unal; D Ersanli; A H Bilge
Journal:  Br J Ophthalmol       Date:  2008-10-01       Impact factor: 4.638

9.  SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

Authors:  Elodie Bousquet; Talal Beydoun; Pierre-Raphaël Rothschild; Ciara Bergin; Min Zhao; Rui Batista; Marie-Laure Brandely; Benedicte Couraud; Nicolette Farman; Alain Gaudric; François Chast; Francine Behar-Cohen
Journal:  Retina       Date:  2015-12       Impact factor: 4.256

10.  Topical nepafenac in treatment of acute central serous chorioretinopathy.

Authors:  Zeynep Alkin; Ozen Ayranci Osmanbasoglu; Abdullah Ozkaya; Gonul Karatas; Ahmet Taylan Yazici
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.